We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Manufacturers: Persevere Therapeutics
Misetionamide is a first-in-class inhibitor of MYC, a protein involved in cancer-cell growth that has historically been difficult to target therapeutically.
